Literature DB >> 10872152

Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas.

T Tamiya1, K Kinoshita, Y Ono, K Matsumoto, T Furuta, T Ohmoto.   

Abstract

We examined whether proton magnetic resonance spectroscopy (MRS) could provide accurate information on histological grade and cell proliferation in astrocytomas. We studied 23 patients with astrocytomas: five grade II, 10 grade III and eight with grade IV (glioblastoma multiforme). We performed proton MRS and determined the Ki-67 labeling index (LI), a tumour proliferation marker, in the same areas of the astrocytomas, and examined the statistical relationship between proton MRS and Ki-67 LI. The N-acetylaspartate (NAA)/creatine-phosphocreatine (Cr) and NAA/choline (Cho)-containing compound ratios were always significantly lower and the Cho/Cr ratios significantly higher than those for normal brain. The Cho/Cr ratio correlated positively and the NAA/Cho ratio inversely with Ki-67 LI. These findings suggest that the Cho signal in proton MRS reflects cellular proliferation. In Kaplan-Meier survival analysis, there was no significant difference between high (> 2.0, 14 cases) and low (< 2.0, 9 cases) Cho/cr ratio groups.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10872152     DOI: 10.1007/s002340050894

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  27 in total

1.  Unusual MR spectroscopic imaging pattern of an astrocytoma: lack of elevated choline and high myo-inositol and glycine levels.

Authors:  Ana Londoño; Mauricio Castillo; Diane Armao; Lester Kwock; Kinuko Suzuki
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

Review 2.  Pediatric surgical neuro-oncology: current best care practices and strategies.

Authors:  James T Rutka; John S Kuo
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

3.  Positive correlations between cerebral choline and renal dysfunction in chronic renal failure.

Authors:  Osamu Sasaki; Noriaki Hattori; Hajime Nakahama; Noriko Inoue; Satoko Nakamura; Takashi Inenaga; Shigeru Kohno; Tohru Sawada; Yuhei Kawano
Journal:  Neuroradiology       Date:  2006-04-04       Impact factor: 2.804

Review 4.  Management of newly diagnosed glioblastoma: guidelines development, value and application.

Authors:  Jeffrey J Olson; Camilo E Fadul; Daniel J Brat; Srinivasan Mukundan; Timothy C Ryken
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

5.  Neuroradiological assessment of newly diagnosed glioblastoma.

Authors:  Srini Mukundan; Chad Holder; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2008-08-20       Impact factor: 4.130

6.  Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.

Authors:  C Su; C Liu; L Zhao; J Jiang; J Zhang; S Li; W Zhu; J Wang
Journal:  AJNR Am J Neuroradiol       Date:  2017-07-20       Impact factor: 3.825

7.  Relationship between choline and apparent diffusion coefficient in patients with gliomas.

Authors:  Inas S Khayal; Forrest W Crawford; Suja Saraswathy; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Tracy R McKnight; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

8.  Role of perfusion CT in glioma grading and comparison with conventional MR imaging features.

Authors:  S K Ellika; R Jain; S C Patel; L Scarpace; L R Schultz; J P Rock; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

9.  Metabolism of diffuse intrinsic brainstem gliomas in children.

Authors:  Ashok Panigrahy; Marvin D Nelson; Jonathan L Finlay; Richard Sposto; Mark D Krieger; Floyd H Gilles; Stefan Blüml
Journal:  Neuro Oncol       Date:  2007-11-14       Impact factor: 12.300

10.  Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS).

Authors:  M Lindskog; P Kogner; F Ponthan; P Schweinhardt; B Sandstedt; T Heiden; G Helms; C Spenger
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.